Description
IGF OT::ONCOLOGY DX COLON:: IGF OT
First action · last action
2015-01-12 · 2015-01-12
Transactions
1
First transaction's obligation
$3,104
Base + all options value (sum of deltas)
$3,104
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325411 · MEDICINAL AND BOTANICAL MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-01-12+$3,104= $3,104
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-01-12 | +$3,104 | $3,104 | IGF OT::ONCOLOGY DX COLON:: IGF OT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RHN3L7SBF7J6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0377 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $55,912 | FY2026 |
| 36C26225N0452 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $114,305 | FY2025 |
| 36C26224N0385 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $114,305 | FY2024 |
| 36C26223P1608 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $10,362 | FY2023 |
| 36C26223N0393 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $194,070 | FY2023 |
| 36C26223A0031 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2023 |
Other recipients under 6505 from 595-LEBANON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24415F0133 | PFIZER INC | 595-LEBANON | $13,397 | FY2015 |
| VA24414F3419 | ACTELION PHARMACEUTICALS US, INC. | 595-LEBANON | $4,275 | FY2014 |
| VA24414F3268 | ACTELION PHARMACEUTICALS US, INC. | 595-LEBANON | $4,275 | FY2014 |
| VA24414P2980 | MCKESSON PLASMA AND BIOLOGICS LLC | 595-LEBANON | $12,598 | FY2014 |
| VA24414F2868 | ACTELION PHARMACEUTICALS US, INC. | 595-LEBANON | $4,275 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24415P1815_3600_-NONE-_-NONE- · retrieved 2026-09-26.